Lung macrophages play a pivotal role in diseases like idiopathic pulmonary fibrosis. Two types of macrophages—the white blood ...

The NOX-targeted therapy market is expected to expand significantly over the upcoming years as more therapies move into late-stage developmen ...

Results of an autopsy-based study revealed that sudden cardiac death and multiorgan pathology may be more closely linked to SSc than previously thought.

In interstitial lung disease (ILD), quantitative computed tomography (qCT) is effective for prognosticating and for disease monitoring.

Altimmune, Inc.'s Pemvidutide shows promise in MASH treatment with liver improvements and safety, despite market overreaction. Click for my ALT stock update.

Although the SYMMETRY Phase IIb trial of the FGF21 analogue efruxifermin did not meet its primary endpoint at 36 weeks, ...

He, L., Zhou, Y., Wang, Q.T., Liu, J. and Ma, J.P. (2025) Two Pathological Patterns in Different Stages of the Same Disease. Journal of Biosciences and Medicines, 13, 189-195. doi: ...

Over the coming months, the Pulmonary Fibrosis Foundation's 2025 PFF Walk will aim to raise more than $1 million for the ...

Announcing a new article publication for BIO Integration journal. Liver fibrosis is caused by excessive extracellular matrix ...

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Myocardial fibrosis was significantly more common among individuals with SSc vs controls (82% vs 31%; OR, 10.7; 95% CI, 4.1-28.7; P <.01). Fibrosis could not be explained by coronary artery disease, ...